University of Helsinki at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

University of Helsinki brings 2 presentations to ENA 2026 in Barcelona. Its posters cover drug screening and preclinical models in breast cancer and bone cancer. A MYC synthetic lethal screen points to an uncharacterized polo-like kinase 1 vulnerability in MYC-high triple-negative breast cancer cells, and bone-derived extracellular matrices are shown to shape osteosarcoma drug response and invasion.

OrganizationENA 2026 Attendance
University of Helsinki
Helsinki, Finland
Universities & institutes
Public research university in Finland with a faculty of medicine and cancer research programmes.

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Helsinki

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction